Literature DB >> 32049441

Ambulatory blood pressure monitoring over 24 h: A Latin American Society of Hypertension position paper-accessibility, clinical use and cost effectiveness of ABPM in Latin America in year 2020.

Ramiro A Sánchez1, José Boggia2, Ernesto Peñaherrera3, Weimar Sebba Barroso4, Eduardo Barbosa5, Raúl Villar6, Leonardo Cobos7, Rafael Hernández Hernández8, Jesús Lopez9, José Andrés Octavio10, José Z Parra Carrillo11, Agustín J Ramírez1, Gianfranco Parati12,13.   

Abstract

Accurate office blood pressure measurement remains crucial in the diagnosis and management of hypertension worldwide, including Latin America (LA). Office blood pressure (OBP) measurement is still the leading technique in LA for screening and diagnosis of hypertension, monitoring of treatment, and long-term follow-up. Despite this, due to the increasing awareness of the limitations affecting OBP and to the accumulating evidence on the importance of ambulatory BP monitoring (ABPM), as a complement of OBP in the clinical approach to the hypertensive patient, a progressively greater attention has been paid worldwide to the information on daytime and nighttime BP patterns offered by 24-h ABPM in the diagnostic, prognostic, and therapeutic management of hypertension. In LA countries, most of the Scientific Societies of Hypertension and/or Cardiology have issued guidelines for hypertension care, and most of them include a special section on ABPM. Also, full guidelines on ABPM are available. However, despite the available evidence on the advantages of ABPM for the diagnosis and management of hypertension in LA, availability of ABPM is often restricted to cities with large population, and access to this technology by lower-income patients is sometimes limited by its excessive cost. The authors hope that this document might stimulate health authorities in each LA Country, as well as in other countries in the world, to regulate ABPM access and to widen the range of patients able to access the benefits of this technique.
© 2020 Wiley Periodicals, Inc.

Entities:  

Keywords:  Latin America; ambulatory blood pressure monitoring; arterial hypertension; hypertension diagnosis and management

Mesh:

Year:  2020        PMID: 32049441      PMCID: PMC8030035          DOI: 10.1111/jch.13816

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  100 in total

1.  Masked hypertension.

Authors:  Thomas G Pickering; Karina Davidson; William Gerin; Joseph E Schwartz
Journal:  Hypertension       Date:  2002-12       Impact factor: 10.190

2.  European Society of Hypertension International Protocol for the validation of blood pressure monitors: a critical review of its application and rationale for revision.

Authors:  George S Stergiou; Nikos Karpettas; Neil Atkins; Eoin O'Brien
Journal:  Blood Press Monit       Date:  2010-02       Impact factor: 1.444

3.  Long-term risk of sustained hypertension in white-coat or masked hypertension.

Authors:  Giuseppe Mancia; Michele Bombelli; Rita Facchetti; Fabiana Madotto; Fosca Quarti-Trevano; Hernan Polo Friz; Guido Grassi; Roberto Sega
Journal:  Hypertension       Date:  2009-06-29       Impact factor: 10.190

4.  Noninvasive Estimation of Aortic Stiffness Through Different Approaches.

Authors:  Paolo Salvi; Filippo Scalise; Matteo Rovina; Francesco Moretti; Lucia Salvi; Andrea Grillo; Lan Gao; Corrado Baldi; Andrea Faini; Giulia Furlanis; Antonio Sorropago; Sandrine C Millasseau; Giovanni Sorropago; Renzo Carretta; Alberto P Avolio; Gianfranco Parati
Journal:  Hypertension       Date:  2019-05-28       Impact factor: 10.190

5.  Guidelines on the management of arterial hypertension and related comorbidities in Latin America.

Authors: 
Journal:  J Hypertens       Date:  2017-08       Impact factor: 4.844

Review 6.  Ambulatory blood pressure improves prediction of cardiovascular risk: implications for better antihypertensive management.

Authors:  Lawrence R Krakoff
Journal:  Curr Atheroscler Rep       Date:  2013-04       Impact factor: 5.113

7.  Successive blood pressure measurements to evaluate suspected and treated hypertension.

Authors:  Marco A Vieira da Silva; Ana P Mendes da Silva; Dante M Artigas Giorgi; Fernando Ganem
Journal:  Blood Press Monit       Date:  2016-04       Impact factor: 1.444

8.  Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research.

Authors:  Thomas G Pickering; John E Hall; Lawrence J Appel; Bonita E Falkner; John Graves; Martha N Hill; Daniel W Jones; Theodore Kurtz; Sheldon G Sheps; Edward J Roccella
Journal:  Circulation       Date:  2005-02-08       Impact factor: 29.690

9.  Prevalence, Awareness, Treatment, and Control of Hypertension in the Southern Cone of Latin America.

Authors:  Adolfo L Rubinstein; Vilma E Irazola; Matias Calandrelli; Chung-Shiuan Chen; Laura Gutierrez; Fernando Lanas; Jose A Manfredi; Nora Mores; Rosana Poggio; Jacqueline Ponzo; Pamela Seron; Lydia A Bazzano; Jiang He
Journal:  Am J Hypertens       Date:  2016-12-01       Impact factor: 2.689

10.  Twenty-four hour Blood Pressure in Obese Patients with Moderate-to-Severe Obstructive Sleep Apnea.

Authors:  Claudia M Correa; Ronaldo A Gismondi; Ana Rosa Cunha; Mario F Neves; Wille Oigman
Journal:  Arq Bras Cardiol       Date:  2017-09-04       Impact factor: 2.000

View more
  6 in total

1.  [2021 World Health Organization guideline on pharmacological treatment of hypertension: Policy implications for the region of the AmericasDiretrizes de 2021 da Organização Mundial da Saúde sobre o tratamento medicamentoso da hipertensão arterial: repercussões para as políticas na região das Américas].

Authors:  Norm R C Campbell; Melanie Paccot Burnens; Paul K Whelton; Sonia Y Angell; Marc G Jaffe; Jennifer Cohn; Alfredo Espinosa Brito; Vilma Irazola; Jeffrey W Brettler; Edward J Roccella; Javier Isaac Maldonado Figueredo; Andres Rosende; Pedro Ordunez
Journal:  Rev Panam Salud Publica       Date:  2022-05-10

Review 2.  2021 World Health Organization guideline on pharmacological treatment of hypertension: Policy implications for the region of the Americas.

Authors:  Norm R C Campbell; Melanie Paccot Burnens; Paul K Whelton; Sonia Y Angell; Marc G Jaffe; Jennifer Cohn; Alfredo Espinosa Brito; Vilma Irazola; Jeffrey W Brettler; Edward J Roccella; Javier Isaac Maldonado Figueredo; Andres Rosende; Pedro Ordunez
Journal:  Lancet Reg Health Am       Date:  2022-05

3.  [2021 World Health Organization guideline on pharmacological treatment of hypertension: Policy implications for the Region of the AmericasDirectrices de la Organización Mundial de la Salud del 2021 sobre el tratamiento farmacológico de la hipertensión: implicaciones de política para la Región de las Américas].

Authors:  Norm R C Campbell; Melanie Paccot Burnens; Paul K Whelton; Sonia Y Angell; Marc G Jaffe; Jennifer Cohn; Alfredo Espinosa Brito; Vilma Irazola; Jeffrey W Brettler; Edward J Roccella; Javier Isaac Maldonado Figueredo; Andres Rosende; Pedro Ordunez
Journal:  Rev Panam Salud Publica       Date:  2022-05-10

4.  Is Office Blood Pressure Measurement Reliable in Obese Adolescents?

Authors:  Derya Tepe; Songül Yılmaz
Journal:  Diabetes Metab Syndr Obes       Date:  2021-09-01       Impact factor: 3.168

5.  Are Differences in Inflammatory Markers between Patients with and without Hypertension-Mediated Organ Damage Influenced by Circadian Blood Pressure Abnormalities?

Authors:  Nestor Vazquez-Agra; Ana-Teresa Marques-Afonso; Anton Cruces-Sande; Ignacio Novo-Veleiro; Jose-Enrique Lopez-Paz; Antonio Pose-Reino; Alvaro Hermida-Ameijeiras
Journal:  J Clin Med       Date:  2022-02-25       Impact factor: 4.241

Review 6.  Ambulatory blood pressure monitoring over 24 h: A Latin American Society of Hypertension position paper-accessibility, clinical use and cost effectiveness of ABPM in Latin America in year 2020.

Authors:  Ramiro A Sánchez; José Boggia; Ernesto Peñaherrera; Weimar Sebba Barroso; Eduardo Barbosa; Raúl Villar; Leonardo Cobos; Rafael Hernández Hernández; Jesús Lopez; José Andrés Octavio; José Z Parra Carrillo; Agustín J Ramírez; Gianfranco Parati
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-02-12       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.